HF4881

Purpose

This bill reorganizes and expands regulatory oversight and licensing across health plan purchasers, prescription drug affordability, and nondepository financial institutions in Minnesota. It also adds new requirements for virtual currency activities. The changes include shifting certain regulatory duties to the Commissioner of Commerce, creating price-transparency provisions for expensive drugs, and strengthening recordkeeping and licensing rules for lenders and currency-related activities.

Key Provisions

• Health plan regulation and funding (Article 1)

  • Transfers regulatory responsibility for health maintenance organizations (HMOs) and county-based purchasers from other agencies to the Commissioner of Commerce.
  • Provides an appropriation of 1,750,000 from the general fund in fiscal year 2027 to support this regulation.
  • Requires reductions in the Department of Health’s FY2027 budgets (general fund by 1,750,000 and state government special revenue by 1,836,000) to account for the transfer; the reductions are ongoing.

• Prescription drug affordability oversight (Article 2)

  • Updates conflict of interest rules for members of the Prescription Drug Affordability Advisory Council and related board.
  • Requires disclosure of conflicts of interest before serving and recusal from matters involving drugs with conflicts.
  • Establishes criteria for identifying prescription drug products with affordability concerns (based on price increases, wholesale acquisition cost (WAC) thresholds, and specific price-change tests over time).
  • The board, with input from the advisory council and the health commissioner, may identify drugs with affordability challenges beyond the listed criteria (including drugs needed for public health emergencies).
  • Requires public availability of the identified drug names and related price information, with specific protections for proprietary data and other confidential information.
  • Repeals certain existing statutory provisions (62J.86(2) and 62J.88) as part of the changes.

• Nondepository financial institutions and lending regulation (Article 3)

  • Transfers or expands regulatory authority for a wide range of lenders and financial activities to the Commissioner of Commerce.
  • Includes health plan purchasers, banks, savings banks, mortgage originators/servicers, and other supervised financial entities.
  • Broadly authorizes regulation of loans, real estate mortgages, purchases of loan portfolios, and related activities, including some federal participant programs.
  • Redefines key lending terms to support Minnesota’s licensing framework.
  • Introduces and clarifies definitions for consumer loans, credit, finance charges, APR, credit cards, and credit sales.
  • Consumer loans and licensing (Sections 2-4)
  • Expands the definition of consumer loans and outlines how finance charges are treated.
  • Sets licensing standards for lenders under the chapter and clarifies when certain federal or government-related entities are exempt from licensing.
  • Virtual currency activities (Article 3, Sec.5)
  • Adds licensing and regulatory requirements for virtual currency businesses.
  • Requires tangible net worth calculations (with specifics on how to treat virtual currency), five-year transaction records, and detailed ongoing recordkeeping, including identities, transaction forms, amounts, dates, and counterparties.
  • Requires general ledger maintenance, monthly postings, and reporting into state records and the NMLS (Nationwide Multistate Licensing System).
  • Other licensing and regulatory alignment (Articles 3, Sec.6-9)
  • Adjusts how certain credit sales and other financing arrangements are regulated or treated under Minnesota law.
  • Aligns license posting requirements and general license administration to ensure transparency and compliance.

Significant Changes to Law

• Administrative realignment

  • Shifts regulatory duties for HMOs and county-based purchasers from existing agencies to the Commissioner of Commerce, with a corresponding budget realignment.

• Drug pricing transparency

  • Introduces formal criteria to identify high-cost or rapidly increasing drugs and requires public disclosure of prices for those products, subject to certain data protections.

• Expanded licensing for financial activities

  • Broadly expands the scope of entities and activities regulated by the Commissioner of Commerce, including nondepository lenders and mortgage-related activities.
  • Establishes new or clarified definitions for terms like consumer loan, finance charge, APR, and credit sale to support licensing and consumer protection.
  • Requires more comprehensive recordkeeping for virtual currency businesses, including five-year transaction histories and reconciliations.

• Virtual currency regulation

  • Creates specific requirements for virtual currency businesses, including capital/financial standards and extensive reporting obligations.

• Repeals and statutory alignment

  • Repeals certain existing sections related to drug affordability and makes targeted updates to multiple statutes to align with the new regulatory structure.

Potential Impacts

• Regulatory oversight

  • More centralized regulation of health plan purchasers and HMOs under a single state agency, which could affect oversight practices and administrative processes.

• Drug affordability

  • Increased price transparency for selected expensive or rapidly increasing drugs, potentially influencing costs for state programs and patients.

• Financial services

  • Expanded licensing and oversight for a broader set of lenders and financial activities, potentially affecting compliance burdens and consumer protections.

• Virtual currency

  • New regulatory burdens on virtual currency businesses, with a focus on financial safeguards and traceability.

How it Would Operate

• Agencies involved would implement the transfer of regulatory responsibilities, apply the new criteria for identifying drug affordability concerns, publish identified drug price information (with protections for proprietary data), and enforce the revised licensing and recordkeeping requirements for lenders and virtual currency businesses through the Minnesota Department of Commerce and related mechanisms (including NMLS and state data systems).

Relevant Terms - health maintenance organizations (HMOs) - county-based purchasers - Commissioner of Commerce - Department of Health - Prescription Drug Affordability Advisory Council - conflict of interest - wholesale acquisition cost (WAC) - CPI (Consumer Price Index) - public data / proprietary data / trade secret - nondepository institutions - consumer loan - finance charge - annual percentage rate (APR) - virtual currency - tangible net worth - NMLS (Nationwide Multistate Licensing System) - mortgage originator / servicer - mortgage loans / real property - license to be posted - related licensing exemptions (e.g., federally insured or government programs)